(IN BRIEF) ZEISS Ventures has participated in the latest funding round of Maculaser, a Finnish medtech company developing a patented, non-damaging, temperature-controlled retinal laser therapy. The round, co-led by ZEISS Ventures and M2care, will help Maculaser begin clinical development of … Read the full press release
